This site is intended for health professionals only

Editor’s pick

Results of suspended trial released
Results of suspended trial released
Myelodysplastic syndrome “manageable”
Myelodysplastic syndrome “manageable”
High cure rates for CAP drug
High cure rates for CAP drug
Pfizer announce oncology investment
Pfizer announce oncology investment
New impetigo treatment launched
New impetigo treatment launched
Striking fear into the hearts of oncologists… but not neurologists
Striking fear into the hearts of oncologists… but not neurologists
European application for US constipation treatment
European application for US constipation treatment
Alzheimer’s treatment breakthrough
Alzheimer’s treatment breakthrough
NHS “penalising” cancer sufferers
NHS “penalising” cancer sufferers
High response for head and neck treatment
High response for head and neck treatment
Drug offers hope on blood cancer
Drug offers hope on blood cancer
“New standard” for lung cancer
“New standard” for lung cancer
1 … 191 192 193 194 195 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x